ArticleOncology letters2019
Serum miR-22 may be a biomarker for papillary thyroid cancer.
Deping Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this paperpooled itcites it
ArticleOncology letters2019
Deping Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.